Showing results (1-10 of 67) with videos related to
Sort By:
Pageof 7
Nutrients|December 17, 2024
FODMAP Diet in Celiac Disease and Gluten-Related DisordersPaolo Usai Satta, Giammarco Mocci, Mariantonia LaiTherapeutics and Clinical Risk Management|February 12, 2009
Treatment of Crohn's disease with colony-stimulating factors: An overviewLuisa Guidi, Giammarco Mocci, Manuela Marzo, et al.Expert Opinion on Biological Therapy|February 7, 2024
Clinical use of biologics for Crohn's disease in adults: lessons learned from real-world studiesAntonio Tursi, Giammarco Mocci, Angelo Del Gaudio, et al.Reviews on Recent Clinical Trials|July 25, 2024
Impact of a Symbiotic Mixture on Moderate-to-severe Diverticular Disease of the ColonAntonio Tursi, Giammarco Mocci, Paolo Usai Satta, et al.Scientific Reports|December 27, 2024
Lack of association between common polymorphisms associated with successful aging and longevity in the population of Sardinian Blue ZoneAlessandra Errigo, Maria Pina Dore, Giammarco Mocci, et al.Journal of Crohn'S & Colitis|March 5, 2013
Dermatological adverse reactions during anti-TNF treatments: focus on inflammatory bowel diseaseGiammarco Mocci, Manuela Marzo, Alfredo Papa, et al.European Journal of Gastroenterology & Hepatology|January 20, 2021
Review article: safety of new biologic agents for inflammatory bowel disease in the liverSalvatore Magrì, Luchino Chessa, Mauro Demurtas, et al.Minerva Gastroenterology|October 29, 2024
Switching rate from intravenous to subcutaneous vedolizumab in managing inflammatory bowel diseases is lower than expectedAntonio Tursi, Giammarco Mocci, Walter Elisei, et al.World Journal of Gastroenterology|February 10, 2015
Management of perianal fistulas in Crohn's disease: an up-to-date reviewManuela Marzo, Carla Felice, Daniela Pugliese, et al.Expert Review of Clinical Pharmacology|November 25, 2011
Biological therapies for inflammatory bowel disease: controversies and future optionsAlfredo Papa, Giammarco Mocci, Michele Bonizzi, et al.Pageof 7